Approvals/CIMA-AEMPS/SERETIDE ACCUHALER 50 MICROGRAMOS/100 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN

Approved

STANDARD

SERETIDE ACCUHALER 50 MICROGRAMOS/100 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 032e4d35e0b930b2
Drug Cima Aemps Name: SERETIDE ACCUHALER 50 MICROGRAMOS/100 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN
Register Number: 8324IP
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2023-11-03
Dosage Form: POLVO PARA INHALACIÓN
Dose: 50/100 mcg
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

FLUTICASONA PROPIONATO

0,092 mg

SALMETEROL

0.047 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 3, 2023

Approval ID

032e4d35e0b930b2

Type

Standard